Combined surgical treatment of the cerebral arteriovenous malformations in patients with the torpid course of the disease
Objective – to optimize the results of surgical treatment of the cerebral arteriovenous malformations (AVM) with a torpid clinical course of the disease.
Materials and methods. The results of combined surgical treatment of cerebral AVMs of 36 patients without a history of AVM rupture were analyzed (this variant of clinical course was defined as «torpid»). Patients were treated in the departments of vascular neurosurgery at the Romodanov Neurosurgery Institute NAMS of Ukraine during the period from 2010 till September 2019. Among the patients there were 18 (50 %) men and 18 (50 %) women. The average age of patients was 28.1 years (10–47 years). Clinical, neurological, laboratory, instrumental, functional and morphological methods of examination were used as well as neuroimaging evaluation and follow-up investigation.
Results. The «torpid» course of disease in patients with AVM was presented as heterogeneous epileptiform manifestations in 24 (66.7 %) cases. One (2.8 %) patient had seizure that were combined with internal hydrocephalus, 9 (25 %) patients had different severity cephalalgic syndrome (according to the International classification of headache – 3β). Progressive neurological deficit was detected in 2 (5.55 %) patients. The distribution of AVMs according Spetzler–Martin scale (1986) was as follows: grade I – in 2 (5.55 %) patients, grade II – in 10 (27.8 %), grade III – in 13 (36.1 %), grade IV – in 9 (25.0 %), grade V – in 2 (5.55 %). In most cases (94.44 %), AVMs were supratentorial, and in 2 (5.55 %) cases they were subtentorial. The average AVM size in the largest dimension was 3.7 cm (2.8–6.7 cm). Intranidal aneurysms in the AVM structure were diagnosed in 8 (22.2 %) patients, fistulas – in 7 (19.4 %) cases. In all cases, at the first stage, endovascular embolization (EE) of AVM was performed. All 36 patients underwent 64 endovascular procedures. Curative treatment after 1 stage was performed in 16 (44.4 %) patients, after 2 stages – in 13 (36.1%), after 3 stage – in 6 (16.66 %), and after 4 stage in 1 (2.77 %) patient. In 36 (56.25 %) cases, embolization was performed with Onyx composition (eV3), in 24 (37.5 %) – with n-butylcyanoacrylate, and in 3 (4.7 %) – with their combination. In 1 (1.56 %) patient, the fistula was excluded from the blood flow using detached balloon-catheter. Embolization was supplemented with radiosurgical treatment (RST) in 30 (83.3 %) cases, microsurgical removal – in 2 (5.55 %), radiotherapy – in 2 (5.55 %) patients. In 1 (2.77 %) case EE was combined with shunting procedure and RST. One (2.77 %) patient after EE with RST suffered hemorrhagic stroke with intracerebral hematoma formation. An operation was performed for hematoma removal and partially functioning AVM resection. In 7 (10.9 %) cases after EE of AVM, patients developed motor deficits. At the time of discharge, they regressed completely in 6 patients, and partially in 1 patient. In (1.5 %) case homonymous hemianopsia had occurred. After RST, total obliteration of AVM was achieved in 17 (58.6 %) patients, in 5 (17.2 %) – subtotal (repeated RST was recommended). In 7 (24.1 %) cases, positive signs of AVM obliteration was noted, and the timing of radiation exposure did not reach the recommended ones. In 2 (3.1 %) patients after microsurgical resection, the AVM was removed completely, which was confirmed by cerebral angiography. After radiotherapy, decreasing of the AVM size and a positive neurological dynamics were noted. There were no fatal outcomes. According to the modified Rankine scale, patients were distribution to group 0 (33 (91.7 %)) and group I (3 (8.3 %)).
Conclusions. The obtained data indicate the promising result of combined surgical treatment of cerebral AVM with a torpid type of clinical manifestations. The leading technique in the applied staged combined surgical treatment of AVM was EE. Its successful use is due to the effectiveness of its impact on all components of the «complex» AVM.
Crawford PM, West CR, Chadwick DW, Shaw MD. Arteriovenous malformations of the brain: natural history in unoperated patients. J. Neurol. Neurosurg. Psychaitry. 1986. Vol.49(1):1-10. PMID: 3958721. PMCID: PMC1028639. DOI: 10.1136/jnnp.49.1.1
Karlsson B, Jokura H, Yang HC et al. The NASSAU (New ASSessment of cerebral Arteriovenous Malformations yet Unruptured) Analysis: are the results from the ARUBA trial also applicable to unruptured arteriovenous malformations deemed suitable for Gamma Knife surgery? Neurosurgery. 2019;85(1):E118-E124. doi:10.1093/neuros/nyy391/.
Hofmeister C, Stapf C, Hartmann A et al. Demographic, morphological, and clinical characteristics of 1289 patients with brain arteriovenous malformation. Stroke. 2000;31(6):1307-10. PMID: 10835449. DOI: 10.1161/01.str.31.6.1307
Steiger H-J, Schmid-Elaesser R, Maucevic A et al. Neurosurgery of arteriovenous malformations and fistulas: a multimodal approach. Springer Verlag; 2002. 469 p.
Brown RD. Epidemiology and natural history of vascular malformations of the central nervous system In: Jaffar JJ, Awad IA, Rosenwasser RH, editors. Vascular malformations of the central nervous system.1999. p.129-47.
Brown RD, Wiebers DO, Torner JC, O’Fallon WM. Incidence and prevalence of intra- cranial vascular malformations in Olmsted County, Minnesota, 1965 to 1992. Neurology.1996;46(4):949-52. PMID: 8780070. DOI: 10.1212/wnl.46.4.949
Magro E, Gentric JC, Darsaut TE et al. Responses to ARUBA: a systematic review and critical ana-lysis for the design of future arteriovenous malformation trials. J Neurosurg. 2017;126(2):486-94. doi: 10.3171/2015.6.JNS15619/.
Luksik AS, Law J, Yang W et al. Assessing the role of preoperative embolization in the surgical, management of cerebral arteriovenous malformations. World Neurosurgery. 2017;104:430-41. doi: 10.1016/j.wneu.2017.05.026
Ogilvy CS, Stieg PE, Awad I et al. Recommendations for the Management of Intracranial Arteriovenous Malformations: A Statement for Healthcare Professionals from a Special Writing Group of the Stroke Council, American Stroke Association. Stroke. 2001;32(5):1458-71. PMID: 11387517. DOI: 10.1161/01.str.32.6.1458
Forster DM, Steiner L, Hakanson S. Arteriovenous malformations of the brain: a long- term clinical study. J. Neurosurg. 1972;37(5):562-70. PMID: 5076373. DOI: 10.3171/jns.1972.37.5.0562
Fults D, Kelly DL. Natural history of arteriovenous malformations of the brain: a clinical study. Neurosurgery. 1984;15(5):658-62. PMID: 6504280. DOI:10.1227/00006123-198411000-00003
Graf CJ, Perret GE, Torner JC. Bleeding from cerebral arteriovenous malformations as part of their natural history. J. Neurosurg. 1983;58(3):331-7. PMID:6827317. DOI: 10.3171/jns.1983.58.3.0331
Mast H, Young WL, Koennecke HC et al. Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet.1997;350(9084):1065-8. PMID: 10213548. DOI: 10.1016/s0140-6736(97)05390-7
Brown RD, Wiebers DO, Forbes GS. Unruptured intracranial aneurysms and arteri- ovenous malformations: frequency of intracranial hemorrhage and relationship of lesions. J. Neurosurg.1990;73(6):859-63. PMID: 2230969. DOI: 10.3171/jns.1990.73.6.0859
Miyachi S, Izumi T, Satow T et al. Effectiveness of preradiosurgical embolization with NBCA for arteriovenous malformations – retrospective outcome analysis in a japanese registry of 73 patients (J-REAL study). Neurointervention. 2017;12(2):100-9. doi: 10. 5469/neuroint.2017.12.2.100
Miyasaka Y, Yada K, Ohwada T et al. An analysis of the venous drainage system as a factor in hemorrhage from arteriovenous malformations. J. Neurosurg.1992;76(2):239-43. PMID: 1730953. DOI: 10.3171/jns.1992.76.2.0239
Morgan MK, Davidson AS, Assaad NNA, Stoodley MA. Critical review of brain AVM surgery, surgical results and natural history in 2017. Acta Neurochir. 2017;159:1457-78. PMID: 28555270. DOI: 10.1007/s00701-017-3217-x
Strauss I, Haim O, Umansky D et al. Impact of onyx embolization on radiosurgical management of cerebral arteriovenous malformations: treatment and outcome. World Neurosurg. 2017;108:656-61. doi: 10.1016/j.wneu.2017.08.188.
Beltramello A, Zampieri P, Ricciardi GK et al. Ope-rative classification of brain arteriovenous malformations. Interventional Neuroradiology. 2008;14(1):9-19. doi: 10.1177/159101990801400102
Blackburn SL, Ashley WW Jr., Rich KM et al. Combined endovascular embolization and stereotactic radiosurgery in the treatment of large arteriovenous malformations. J. Neurosurg. 2011;114(6):1758-67. doi: 10.3171/2011.1.JNS10571.
Hernesniemi JA, Dashti R, Juvela S et al. Natural history of brain arteriovenous malformations: a long-term follow-up study of risk of hemorrhage in 238 patients. Neurosurgery. 2008;63(5):823-31. PMID: 19005371. DOI: 10.1227/01.NEU.0000330401.82582.5E
Langer DJ, Lasner TM, Hurst RW et al. Hypertension, small size, and deep venous drainage are associated with risk of hemorrhagic presentation of cerebral arteriovenous malformations. Neurosurgery. 1998;42(3):481-6. PMID: 9526981. DOI: 10.1097/00006123-199803000-00008
Pollock BE, Flickinger JC, Lunsford LD et al. Factors that predict the bleeding risk of cerebral arteriovenous malformations. Stroke.1996;27(1):1-6. PMID: 8553382. DOI: 10.1161/01.str.27.1.1
Solomon RA, Connolly ES Jr. Arteriovenous malformations of the brain. N. Engl, J. Med. 2017;376(19):1859-66. doi: 10/1056/NEJMra1607407.
Abstract views: 104 PDF Downloads: 32